Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Main Street Capital
MAIN
$5.31B
| $3.62M | ﹤0.01% |
72,265
+31,110
| +76% | +$1.56M |
|
2327
BioCryst Pharmaceuticals
BCRX
$2.29B
| $3.62M | ﹤0.01% |
476,672
+250,086
| +110% | +$1.9M |
|
2328
PUT
Truist Financial
TFC
$64.3B
| $3.62M | ﹤0.01% |
+84,700
| New | +$3.58M |
|
2329
Bloomin' Brands
BLMN
$764M
| $3.62M | ﹤0.01% |
219,080
+59,723
| +37% | +$1.06M |
|
|
PDCO
2330
DELISTED
Patterson Companies, Inc.
PDCO
| $3.62M | ﹤0.01% |
165,715
+44,906
| +37% | +$1.06M |
|
2331
Amphastar Pharmaceuticals
AMPH
$877M
| $3.61M | ﹤0.01% |
74,456
+25,878
| +53% | +$1.14M |
|
2332
Syndax Pharmaceuticals
SNDX
$1.69B
| $3.61M | ﹤0.01% |
187,629
+110,535
| +143% | +$2.28M |
|
2333
CALL
Mastercard
MA
$500B
| $3.6M | ﹤0.01% |
7,300
-77,900
| -91% | -$36.2M |
|
2334
Perella Weinberg Partners
PWP
$1.24B
| $3.6M | ﹤0.01% |
186,387
+1,517
| +0.8% | +$27.8K |
|
2335
SAP
SAP
$226B
| $3.59M | ﹤0.01% |
+15,685
| New | +$3.33M |
|
2336
CALL
Devon Energy
DVN
$50.8B
| $3.59M | ﹤0.01% |
91,800
+6,800
| +8% | +$299K |
|
2337
CALL
KKR & Co
KKR
$97.2B
| $3.59M | ﹤0.01% |
27,500
-12,500
| -31% | -$1.48M |
|
2338
iShares Russell 2000 Value ETF
IWN
$14.7B
| $3.59M | ﹤0.01% |
21,524
-17,228
| -44% | -$2.8M |
|
|
WNS
2339
DELISTED
WNS Holdings
WNS
| $3.58M | ﹤0.01% |
68,007
+52,179
| +330% | +$2.96M |
|
2340
iShares Silver Trust
SLV
$28.8B
| $3.58M | ﹤0.01% |
126,049
+51,352
| +69% | +$1.38M |
|
2341
MYR Group
MYRG
$5.3B
| $3.58M | ﹤0.01% |
34,987
+23,013
| +192% | +$2.61M |
|
2342
Full Truck Alliance
YMM
$10B
| $3.57M | ﹤0.01% |
+395,762
| New | +$3.04M |
|
2343
Structure Therapeutics
GPCR
$3.53B
| $3.56M | ﹤0.01% |
81,138
+40,915
| +102% | +$1.58M |
|
2344
Northwest Bancshares
NWBI
$2.34B
| $3.55M | ﹤0.01% |
265,647
+121,820
| +85% | +$1.6M |
|
|
FYBR
2345
DELISTED
Frontier Communications
FYBR
| $3.55M | ﹤0.01% |
99,969
+28,417
| +40% | +$855K |
|
2346
Sunstone Hotel Investors
SHO
$2.16B
| $3.54M | ﹤0.01% |
343,018
+258,302
| +305% | +$2.64M |
|
|
GTM
2347
ZoomInfo Technologies
GTM
$1.07B
| $3.53M | ﹤0.01% |
342,495
+208,015
| +155% | +$2.18M |
|
|
X
2348
PUT
DELISTED
US Steel
X
| $3.53M | ﹤0.01% |
+100,000
| New | +$3.81M |
|
2349
Universal Technical Institute
UTI
$2.33B
| $3.53M | ﹤0.01% |
217,157
-31,459
| -13% | -$539K |
|
2350
Newmark Group
NMRK
$2.8B
| $3.53M | ﹤0.01% |
227,099
+176,947
| +353% | +$2.3M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.